1-6 of 6
Authors: Marco Bongiovanni
Sort by
Journal Article
Prolonged survival of an HIV-infected subject with severe lymphoproliferative disease and rhinocerebral mucormycosis
Get access
Marco Bongiovanni and others
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 1, July 2007, Pages 192–193, https://doi.org/10.1093/jac/dkm148
Published: 12 May 2007
Journal Article
Subclinical hypothyroidism in HIV-infected subjects
Get access
Marco Bongiovanni and others
Journal of Antimicrobial Chemotherapy, Volume 58, Issue 5, November 2006, Pages 1086–1089, https://doi.org/10.1093/jac/dkl360
Published: 01 September 2006
Journal Article
Treatment interruptions in HIV-infected subjects Free
Marco Bongiovanni and others
Journal of Antimicrobial Chemotherapy, Volume 58, Issue 3, September 2006, Pages 502–505, https://doi.org/10.1093/jac/dkl268
Published: 01 July 2006
Journal Article
Non-nucleoside-reverse-transcriptase-inhibitor-based HAART and osteoporosis in HIV-infected subjects
Get access
Marco Bongiovanni and others
Journal of Antimicrobial Chemotherapy, Volume 58, Issue 2, August 2006, Pages 485–486, https://doi.org/10.1093/jac/dkl229
Published: 02 June 2006
Journal Article
Use of lopinavir/ritonavir in HIV-infected patients failing a first-line protease-inhibitor-containing HAART
Get access
Marco Bongiovanni and others
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 6, June 2005, Pages 1003–1007, https://doi.org/10.1093/jac/dki113
Published: 11 April 2005
Journal Article
Immunovirological outcomes in 70 HIV-1-infected patients who switched to lopinavir/ritonavir after failing at least one protease inhibitor-containing regimen: a retrospective cohort study
Get access
Marco Bongiovanni and others
Journal of Antimicrobial Chemotherapy, Volume 51, Issue 1, January 2003, Pages 171–174, https://doi.org/10.1093/jac/dkg045
Published: 01 January 2003
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals